# Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy

> **NCT03480815** · NA · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 24 (actual)

## Conditions studied

- Severe Allergic Asthma

## Interventions

- **DEVICE:** Nocturnal Temperature Controlled Laminar Flow Device
- **OTHER:** None Device

## Key facts

- **NCT ID:** NCT03480815
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-20
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-06-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03480815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03480815, "Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03480815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*